ACTRN12608000398303
Terminated
Phase 4
Efficacy of low dose escitalopram v's placebo in the amelioration of anxiety and fatigue in patients who are unwell or suffer chronic illness
Mood Research Foundation (WA)0 sites50 target enrollmentAugust 8, 2008
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Chronic illness - patients who are generally unwell for an extended period.
- Sponsor
- Mood Research Foundation (WA)
- Enrollment
- 50
- Status
- Terminated
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Chronic illness \- patients who are generally unwell for an extended period.
Exclusion Criteria
- •Patients with Malignancy or taking any prescribed antidepressant and/or pyschotrophic medication will be excluded from the trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Effect of of escitalopram and relaxation on hot flashes of patients with breast cancerIRCT2017072834482N2Vice chancellor for Research, Kermanshah University of Medical Sciences87
Completed
Phase 2
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11IRCT20211208053331N1Ahvaz University of Medical Sciences172
Recruiting
Phase 3
Treatment of depressive symptoms in patients with heart failureDepression.Major depressive disorder, single episode, mildF32.0IRCT20190525043700N5Babol University of Medical Sciences80
Completed
Phase 3
Escitalopram ?s effectiveness on treatment of depressive disorder and improvement of quality of life in patients who are undergone coronary artery bypass graft surgeryIRCT20140126016374N2niversity of social welfare and rehabilitation sciences50
Active, not recruiting
Phase 1
A Randomised Controlled Trial of Escitalopram and Nortriptyline compared with placebo, and standard psychological care, for depression in Parkinson’s diseaseDepression in Parkinson's diseaseMedDRA version: 20.0Level: PTClassification code 10012378Term: DepressionSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2018-002942-35-GBniversity College London Comprehensive Clinical Trials Unit408